Business context and reporting period
General Catalyst Global Resilience Merger Corp. is a Cayman Islands blank-check company formed on January 14, 2026 to pursue a business combination. This unaudited Form 10-Q covers the quarter ended September 30, 2026; the company had not selected a target and had no operating revenue. The IPO closed May 1, 2026.
Financial results and position
- Quarter net income: $3.39 million, comprising $3.65 million of trust-account interest less $258,693 of general and administrative expense. Net income per share was $0.07 for both redeemable Class A and non-redeemable Class A/Class B shares.
- Inception through September 30: Net income was $5.17 million, on $5.89 million of trust interest and $719,632 of general and administrative expense. Net income per share was $0.18 for both share groupings.
- Assets and liquidity: Total assets were $409.11 million, including $408.39 million held in trust and $477,704 of cash outside the trust. Working capital surplus was $200,261.
- Cash flow: Inception-to-date operating cash used was $505,947; investing cash used was $402.50 million; financing cash provided was $403.48 million. Ending cash was $477,704.
- Debt and obligations: No working-capital loans were outstanding and the company reported no long-term debt. Liabilities totaled $14.53 million, including a $14.09 million deferred underwriting fee payable upon a completed business combination.
- Margins: Not meaningful for this pre-combination company, which has no operating revenue.
Changes, outlook and key risks
- The filing provides no prior-year comparable results; the company began operations in 2026. The quarter’s income primarily reflects interest earned on trust assets, not business operations.
- The IPO raised $402.50 million gross; a further $9.05 million came from private-placement securities. The trust held $408.39 million at quarter-end. The company expects to use substantially all trust funds toward a business combination.
- Management expects significant ongoing acquisition-related costs. The Sponsor committed to fund obligations as they come due for one year from release of the financial statements; management says available resources are sufficient for working-capital needs during that period. Additional financing may still be needed, and Sponsor support may not be available beyond its commitment.
- The company must complete a business combination within 24 months of the May 1, 2026 IPO closing, or within 27 months if it enters a qualifying agreement within the first 24 months. If it fails, public shares are to be redeemed and warrants may expire worthless.
- Public shareholders may redeem shares in connection with a business combination. High redemptions, difficulty identifying or completing a target transaction, additional financing needs, conflicts of interest, and geopolitical or market disruption could affect the outcome.
- Alignment Shares transferred to three directors have an estimated grant-date fair value of $18.57 million; no compensation expense was recorded because a business combination was not considered probable. Their performance-based conversion terms and sponsor-related voting and governance rights may affect dilution and shareholder influence.
- No material changes to previously disclosed risk factors, legal proceedings, or subsequent events were reported. Management concluded disclosure controls were effective at a reasonable-assurance level; no material change in internal control was reported.
Important facts for investors to verify
- Whether a target is identified and whether any qualifying agreement or business combination is completed before the applicable deadline.
- Trust balance, redemption value per public share, and likely redemptions and transaction financing at any proposed deal.
- The terms and availability of Sponsor liquidity support, and the Sponsor’s capacity to meet its trust-account indemnity obligations.
- Potential dilution and governance effects from Alignment Share conversions, warrants, working-capital financing, and any securities issued in a transaction.
- Transaction costs, including the $14.09 million deferred underwriting fee, and any changes to the company’s cash outside the trust.